Parkinson's disease and anxiety

Area of Science:

• Neurology
• Psychiatry
• Movement Disorders

Background:

• Parkinson's disease (PD) is a neurodegenerative disorder affecting movement.
• Anxiety is a common and significant comorbidity in PD patients.
• The exact causes of anxiety in PD are not fully understood, with theories including psychological stress and neurochemical alterations.

Purpose of the Study:

• To review the current understanding of anxiety in Parkinson's disease.
• To explore potential etiological factors, including the role of antiparkinsonian medications.
• To identify common anxiety disorder subtypes and the comorbidity with depression in PD.

Main Methods:

• Literature review of studies investigating anxiety in Parkinson's disease patients.
• Analysis of the relationship between PD, anxiety, and depression.
• Examination of potential contributing factors, including medication effects.

Main Results:

• Up to 40% of Parkinson's disease patients experience clinically significant anxiety.
• Anxiety may stem from psychological stress or neurochemical changes associated with PD.
• Anxiety disorders in PD often manifest as panic, phobic, or generalized anxiety disorders.
• Comorbidity of anxiety and depression is higher in PD patients than in the general population.
• Anxiety with depression may indicate a specific subtype of depression in PD.

Conclusions:

• Anxiety is a prevalent issue in Parkinson's disease, impacting patient well-being.
• Further research is needed to elucidate the precise mechanisms driving anxiety in PD.
• There is a lack of clinical trial evidence for anxiety treatments in Parkinson's disease patients, highlighting an unmet clinical need.